The phenotypic modulation in renal arteriolar smooth muscles and the glomerular mesangial cells.

肾小动脉平滑肌和肾小球系膜细胞的表型调节。

基本信息

  • 批准号:
    05670949
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1994
  • 项目状态:
    已结题

项目摘要

In the present study we demonstrated that the phenotypic modulation occurred in smooth muscles of renal arterioles and in glomerular cells during development of hypertension and various glomerular diseases. Salt-loaded stroke-prone-spontaneously hypertensive rats (SHRSP) developed malignant hypertension. In the kidney, the expression of SM2 (muscle-type myosin heavy chain isoform) and alpha-actin was decreased according to the degree of vascular damages. As SM2 is regarded to be expressed in highly differentiated smooth muscles of strong contractility, the decrease in SM2 expression might result in functional abnormalities in arterioles, which accelerates hypertensive glomerular damage. The mesangial cells expressed non-muscle myosin, Smemb, and alpha-actin. In various glomerular diseases, the phenotypic modulation took place in the epithelial cells and in the mesangial cells. These phenotypic modulations were confirmed by the immunoelectron microscopy and also by the northern analysis of messenger RNA.In the anti-thy-1 glomerulonephritis, mesangial cells express alpha-actin from the earlier stage of the disease and also Smemb in the later stage. In the remnant kidney, Smemb was expressed in the mesangial cells at the earlier stage, but in the epithelial cells at the later stage, when the glomerular hypertrophy developed. In the anti-glomerular basement membrane glomerulonephritis and the streptozotocin-induced diabetic kidney, both the epithelial and mesangial cells expressed Smemb. In the remnant kidney, the anti-GBM glomerulonephritis or diabetic kidney, alpha-actin was not expressed at all. Thus, the phenotypic modulation of glomerular cells took place heterogeneously as well as in the varying manner. At present, the functional meaning of the phenotypic modulation of glomerular cells is unknown.
在本研究中,我们证明在高血压和各种肾小球疾病的发展过程中,表型调节发生在肾小动脉平滑肌和肾小球细胞中。含盐的易发生中风的自发性高血压大鼠(SHRSP)出现恶性高血压。在肾脏中,SM2(肌肉型肌球蛋白重链亚型)和α-肌动蛋白的表达根据血管损伤的程度而降低。由于SM2被认为在高度分化、收缩力强的平滑肌中表达,SM2表达减少可能导致小动脉功能异常,从而加速高血压肾小球损伤。系膜细胞表达非肌肉肌球蛋白、Smemb 和 α-肌动蛋白。在各种肾小球疾病中,表型调节发生在上皮细胞和系膜细胞中。这些表型调节通过免疫电镜和信使 RNA 的 Northern 分析得到证实。在抗 thy-1 肾小球肾炎中,系膜细胞在疾病早期表达 α-肌动蛋白,在疾病后期也表达 Smemb。在残肾中,Smemb早期表达于系膜细胞,后期肾小球肥大时表达于上皮细胞。在抗肾小球基底膜肾炎和链脲佐菌素诱导的糖尿病肾中,上皮细胞和系膜细胞均表达Smemb。在残余肾、抗GBM肾小球肾炎或糖尿病肾中,α-肌动蛋白根本不表达。因此,肾小球细胞的表型调节以不同的方式异质地发生。目前,肾小球细胞表型调节的功能意义尚不清楚。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kim ef al.: "Ductus arferosus. Advamced diferntiation of simooth masck cells demonsfrated by myosin heavy chain isoforms eypression." Circulation. 88. 1804-1810 (1993)
Kim 等人:“动脉导管。通过肌球蛋白重链亚型表达证明平滑肌细胞的高级分化。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kim H S,Aikawa M,Kimura K,Kuro-o M,Nakahara K,Suzuki T,Katoh H,Okamoto E,Yazaki Y,Nagai R: "Ductus arteriosus. Advanced differentiation of smooth muscle cells demonstrated by myosin heavy chain isoform expression in rabbits." Circulation. 88. 1804-1810 (1
Kim H S,Aikawa M,Kimura K,Kuro-o M,Nakahara K,Suzuki T,Katoh H,Okamoto E,Yazaki Y,Nagai R:“动脉导管。通过肌球蛋白重链亚型表达证明平滑肌细胞的高级分化
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hiroi, J,Kimura, K,Aikawa, M,Tojo, A,Suzuki, Y,Nagamatu, T,Omata, M,Yazaki, Y,Nagai, R: "Expression of non-muscle type myosin heavy chain isoform, SMemb in glomerular cells in various glomerular diseases." Kidney Int. (in press).
Hiroi,J,Kimura,K,Aikawa,M,Tojo,A,Suzuki,Y,Nagamatu,T,Omata,M,Yazaki,Y,Nagai,R:“非肌肉型肌球蛋白重链亚型的表达,SMemb
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kim,H.S.: "Ductus arteriosus.Advanced differentiation of smooth muscle.Cells demonstrated by myosin heavy chain isoform expression." Circulation. 88. 1804-1810 (1993)
Kim,H.S.:“动脉导管。平滑肌的高级分化。通过肌球蛋白重链亚型表达证明的细胞。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hiroi et al.: "Expression of non-muecle type myosion heavy chain isoforms,SMemb,in glomenular cells ot vamous glomerular diseses" Kidney Int.(in press).
Hiroi 等人:“肾小球细胞或血管性肾小球疾病中非粘液型肌分裂重链同种型 SMemb 的表达”Kidney Int.(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KIMURA Kenjiro其他文献

KIMURA Kenjiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KIMURA Kenjiro', 18)}}的其他基金

Development of high-resolution magnetic field imaging system and application to interface science
高分辨率磁场成像系统开发及其在界面科学中的应用
  • 批准号:
    25870428
  • 财政年份:
    2013
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Intermittent hypoxia in the progression of diabetic nephropathy and Intermittent hypoxia in the progression of diabetic nephropathy and Role of fatty acid binding protein
糖尿病肾病进展中的间歇性缺氧 糖尿病肾病进展中的间歇性缺氧及脂肪酸结合蛋白的作用
  • 批准号:
    21591043
  • 财政年份:
    2009
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of local solvationstructure at solid/liquid interf by frequency modulation atomic force microscopy
调频原子力显微镜研究固/液界面的局部溶剂化结构
  • 批准号:
    20760022
  • 财政年份:
    2008
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Role of renal liver-type fatty acid binding protein in intermittent hypoxia
肾肝型脂肪酸结合蛋白在间歇性缺氧中的作用
  • 批准号:
    19590966
  • 财政年份:
    2007
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms for the Progression of Renal Disease - Fatty Acids as an Aggravating Factor and Fatty Acid Binding Protein as an Ameliorating Factor
肾病进展机制——脂肪酸作为加重因素和脂肪酸结合蛋白作为改善因素
  • 批准号:
    13671099
  • 财政年份:
    2001
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Renal arterioles in development of glomerular sclerosis.
肾小球硬化发展中的肾小动脉。
  • 批准号:
    02670379
  • 财政年份:
    1990
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
  • 批准号:
    82300764
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于“肠-肾”轴理论阐释护肾痛风泰调控ABCG2降尿酸的机制
  • 批准号:
    82305104
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
PPARγ通过Klotho/FGF2信号通路改善DKD肾小管EMT的机制研究及肾元颗粒的干预作用
  • 批准号:
    82360916
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
Tregs中Foxp3活性调节机制在中低剂量氟致肾损伤中的免疫调控作用
  • 批准号:
    82373699
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
同步介导CXCR4通路阻断和线粒体功能恢复的递药系统用于肾纤维化治疗
  • 批准号:
    82304395
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

患者由来kidney-on-a-chipを用いた慢性腎臓病の病態解明と創薬
使用源自患者的肾脏芯片阐明慢性肾脏疾病的病理学和药物发现
  • 批准号:
    24K03249
  • 财政年份:
    2024
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The gut-kidney-heart axis as a driver of cardiovascular disease progression
肠-肾-心轴是心血管疾病进展的驱动因素
  • 批准号:
    MR/Y010051/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Fellowship
Navigate homogenesis nephrogenesis in kidney organoid by microfabrication of 3D extracellular matrix.
通过 3D 细胞外基质的微加工来引导肾脏类器官中的同质肾发生。
  • 批准号:
    24K21098
  • 财政年份:
    2024
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
KitNewCare - Developing a framework/model to environmentally sustainable and climate neutral health and care systems using the Kidney care pathway
KitNewCare - 使用肾脏护理途径开发环境可持续和气候中性的健康和护理系统框架/模型
  • 批准号:
    10110449
  • 财政年份:
    2024
  • 资助金额:
    $ 1.34万
  • 项目类别:
    EU-Funded
Indication selection, patient stratification, and IND preparation for STX-002: the first-in-class LRG1 inhibitor for treatment of chronic kidney disease and immunotherapy-resistant tumours.
STX-002的适应症选择、患者分层和IND准备:用于治疗慢性肾病和免疫治疗耐药肿瘤的一流LRG1抑制剂。
  • 批准号:
    10092585
  • 财政年份:
    2024
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了